{"DataElement":{"publicId":"4917555","version":"1","preferredName":"Patient Genetic Syndrome Diagnosis Type","preferredDefinition":"the type of syndromes passed from parents to offspring through genes in sperm and egg cells to a patient","longName":"PtGntcSydDxTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4917533","version":"1","preferredName":"Patient Genetic Syndrome Diagnosis","preferredDefinition":"information related to the diagnosis of syndromes that is passed from parents to offspring through genes in sperm and egg cells to a patient.","longName":"PtGntcSydDx","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4917531","version":"1","preferredName":"Genetic Syndrome Diagnosis","preferredDefinition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.:a set of symptoms, usually three or more, which occur together and characterize a particular pathological state; for thorough searching see the Permuted Term Index for specific syndromes.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C17938:C28193:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Syndrome","conceptCode":"C28193","definition":"A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7F62E5-D594-1CE6-E050-BB89AD4312A8","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7F62E5-D5A5-1CE6-E050-BB89AD4312A8","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4917553","version":"1","preferredName":"Genetic syndrome Type","preferredDefinition":"the type of syndromes passed from parents to offspring through genes in sperm and egg cells to a patient","longName":"4917553v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hemihypertrophy","valueDescription":"Hemihypertrophy","ValueMeaning":{"publicId":"3078440","version":"1","preferredName":"Hemihypertrophy","longName":"3078440","preferredDefinition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemihypertrophy","conceptCode":"C88541","definition":"A finding indicating the presence of greater than normal asymmetry between the right and left sides of the body. The asymmetry may be manifested in the entire side or part of it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85399A6D-D1E3-B88C-E040-BB89AD431518","latestVersionIndicator":"Yes","beginDate":"2010-04-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D660-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Gorlin syndrome","valueDescription":"Nevoid Basal Cell Carcinoma Syndrome","ValueMeaning":{"publicId":"3210902","version":"1","preferredName":"Nevoid Basal Cell Carcinoma Syndrome","longName":"3210902","preferredDefinition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH gene.  It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida).  Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nevoid Basal Cell Carcinoma Syndrome","conceptCode":"C2892","definition":"An autosomal dominant genetic syndrome caused by abnormalities in the PTCH and SUFU gene. It is characterized by multiple basal cell carcinomas at a young age, odontogenic keratocysts, and skeletal defects (bifurcated and splayed ribs, fusion of vertebrae, spinal bifida). Patients with this syndrome may also develop medulloblastomas and ovarian fibromas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B1D8-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D674-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Cushing syndrome","valueDescription":"Cushing Syndrome","ValueMeaning":{"publicId":"3210809","version":"1","preferredName":"Cushing Syndrome","longName":"3210809","preferredDefinition":"A syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cushing Syndrome","conceptCode":"C2969","definition":"A syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A38C-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D688-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Costello syndrome","valueDescription":"Costello Syndrome","ValueMeaning":{"publicId":"3210988","version":"1","preferredName":"Costello Syndrome","longName":"3210988","preferredDefinition":"A genetic syndrome caused by mutations in the HRAS gene. It is characterized by developmental delay, mental retardation, loose skin folds, cardiomyopathy, tachycardia, and structural heart defects. Patients are at an increased risk of developing benign or malignant neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Costello Syndrome","conceptCode":"C84652","definition":"A genetic syndrome caused by mutations in the HRAS gene. It is characterized by developmental delay, mental retardation, loose skin folds, cardiomyopathy, tachycardia, and structural heart defects. Patients are at an increased risk of developing benign or malignant neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-BE1A-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D69C-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Down syndrome","valueDescription":"Down Syndrome","ValueMeaning":{"publicId":"2730288","version":"1","preferredName":"Down Syndrome","longName":"2730288","preferredDefinition":"A disorder caused by the presence of an extra chromosome 21 and characterized by mental retardation and distinguishing physical features.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Down Syndrome","conceptCode":"C2993","definition":"A chromosomal dysgenesis syndrome resulting from a triplication or translocation of chromosome 21. Down syndrome occurs in approximately 1:700 live births. Abnormalities are variable from individual to individual and may include mental retardation, retarded growth, flat hypoplastic face with short nose, prominent epicanthic skin folds, small low-set ears with prominent antihelix, fissured and thickened tongue, laxness of joint ligaments, pelvic dysplasia, broad hands and feet, stubby fingers, transverse palmar crease, lenticular opacities and heart disease. Patients with Down syndrome have an estimated 10 to 30-fold increased risk for leukemia; most have symptoms of Alzheimer's disease by age 40. Also known as trisomy 21 syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"468669DD-300B-4A98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D6A6-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Central hypoventilation syndrome","valueDescription":"Center Hypoventilation Syndrome","ValueMeaning":{"publicId":"4917554","version":"1","preferredName":"Center Hypoventilation Syndrome","longName":"4917554","preferredDefinition":"A point or area that is approximately central within some larger region or structure.: A state in which there is a reduced amount of air entering the pulmonary alveoli.: a set of symptoms, usually three or more, which occur together and characterize a particular pathological state; for thorough searching see the Permuted Term Index for specific syndromes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Center","conceptCode":"C25445","definition":"A point or area that is approximately central within some larger region or structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hypoventilation","conceptCode":"C50594","definition":"A state in which there is a reduced amount of air entering the pulmonary alveoli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Syndrome","conceptCode":"C28193","definition":"A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7F62E5-D6B4-1CE6-E050-BB89AD4312A8","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D6CD-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Beckwith-Wiedemann syndrome","valueDescription":"Beckwith-Wiedemann Syndrome","ValueMeaning":{"publicId":"2967368","version":"1","preferredName":"Beckwith-Wiedemann Syndrome","longName":"2967368","preferredDefinition":"A genetic syndrome caused by abnormalities in chromosome 11.  It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia.  Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Beckwith-Wiedemann Syndrome","conceptCode":"C34415","definition":"A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, rhabdomyosarcoma) and adrenal cortex carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AB32307-57DC-1A4F-E040-BB89AD43618C","latestVersionIndicator":"Yes","beginDate":"2009-12-14","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-14","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B7F62E5-D6D7-1CE6-E050-BB89AD4312A8","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"ONEDATA","dateModified":"2015-07-22","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-7048-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"WAGR Syndrome","valueDescription":"Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome","ValueMeaning":{"publicId":"3211530","version":"1","preferredName":"Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome","longName":"3211530","preferredDefinition":"A very rare congenital condition involving the complex of Wilms' tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WAGR Syndrome","conceptCode":"C3718","definition":"A very rare congenital condition involving the complex of Wilms tumor, aniridia, genitourinary abnormalities, and mental retardation. Wilms Tumor-Aniridia-Genitourinary Anomalies-Mental Retardation (WAGR) syndrome involves deletions of several adjacent genes in chromosome region 11p13. Two or more of the four conditions must be present for an individual to be diagnosed with WAGR Syndrome. The clinical picture varies, depending upon the combination of abnormalities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0B69-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-705D-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Denys-Drash Syndrome","valueDescription":"Denys-Drash Syndrome","ValueMeaning":{"publicId":"3211013","version":"1","preferredName":"Denys-Drash Syndrome","longName":"3211013","preferredDefinition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Denys-Drash Syndrome","conceptCode":"C84668","definition":"A rare congenital syndrome caused by mutations in the WT1 gene. It is characterized by the presence of congenital nephropathy (diffuse mesangial sclerosis), Wilms tumor, and intersex disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C17E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-7067-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Werner syndrome","valueDescription":"Werner Syndrome","ValueMeaning":{"publicId":"4824452","version":"1","preferredName":"Werner Syndrome","longName":"4824452","preferredDefinition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Werner Syndrome","conceptCode":"C3447","definition":"A rare, autosomal recessive syndrome caused by mutations in the WRN gene. It is characterized by the appearance of accelerated aging following puberty. It is associated with the development of diabetes mellitus, atherosclerosis, cataracts, and cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-444B-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-7073-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Noonan syndrome","valueDescription":"Noonan Syndrome","ValueMeaning":{"publicId":"3211308","version":"1","preferredName":"Noonan Syndrome","longName":"3211308","preferredDefinition":"A genetic syndrome caused by mutations in the PTPN11 gene (over 50% of the cases) or less frequently mutations in the SOS1, RAF1, or KRAS genes.  It is characterized by short stature, webbed neck, hypertelorism, low-set ears, deafness, and thrombocytopenia or abnormal platelet function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Noonan Syndrome","conceptCode":"C34854","definition":"A genetic syndrome caused by mutations in the PTPN11 gene (over 50% of the cases) or less frequently mutations in the SOS1, RAF1, or KRAS genes. It is characterized by short stature, webbed neck, hypertelorism, low-set ears, deafness, and thrombocytopenia or abnormal platelet function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-EBD3-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-7088-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Neurofibromatosis Type I","valueDescription":"Neurofibromatosis Type 1","ValueMeaning":{"publicId":"2962080","version":"1","preferredName":"Neurofibromatosis Type 1","longName":"2962080","preferredDefinition":"Type 1 (peripheral) neurofibromatosis (von Recklinghausen's disease), is the most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath neoplasms, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1","conceptCode":"C3273","definition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BA0E7A-4A8D-2225-E040-BB89AD436E34","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"GDEEN","dateModified":"2023-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-709C-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Li-Fraumeni syndrome","valueDescription":"Li-Fraumeni Syndrome","ValueMeaning":{"publicId":"3211225","version":"1","preferredName":"Li-Fraumeni Syndrome","longName":"3211225","preferredDefinition":"An autosomal dominant hereditary neoplastic syndrome caused by an alteration in the p53 tumor suppressor gene.  It is characterized by the development of malignant neoplasms at various anatomic sites.  The malignant neoplasms associated with Li-Fraumeni syndrome include adrenal cortex carcinoma, astrocytic tumors, colorectal carcinoma, gastric carcinoma, malignant breast neoplasms, medulloblastoma, osteosarcoma, and soft tissue sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Li-Fraumeni Syndrome","conceptCode":"C3476","definition":"An autosomal dominant cancer predisposition syndrome caused by germline mutations of the TP53 gene. It is associated with breast carcinoma, choroid plexus carcinoma, adrenal cortex carcinoma, astrocytic tumors, medulloblastoma, soft tissue sarcoma, osteosarcoma, and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-DF6B-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-70A7-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Hirschsprung disease","valueDescription":"Hirschsprung Disease","ValueMeaning":{"publicId":"4920071","version":"1","preferredName":"Hirschsprung Disease","longName":"4920071","preferredDefinition":"A congenital disorder characterized by the absence of myenteric ganglion cells in the distal colon. It results in a functional stenosis of the distal colon and a massive distention of the proximal colon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hirschsprung Disease","conceptCode":"C34700","definition":"A congenital disorder characterized by the absence of myenteric ganglion cells in the distal colon. It results in a functional stenosis of the distal colon and a massive distention of the proximal colon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B8FCB10-70B1-B06E-E050-BB89AD430721","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-70CC-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Hereditary retinoblastoma","valueDescription":"Hereditary Retinoblastoma","ValueMeaning":{"publicId":"4824454","version":"1","preferredName":"Hereditary Retinoblastoma","longName":"4824454","preferredDefinition":"An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hereditary Retinoblastoma","conceptCode":"C8495","definition":"An inherited malignant tumor that originates in the nuclear layer of the retina. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities affecting the RB1 gene. Patients with the inherited form appear to be at increased risk for secondary non-ocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4486-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B8FCB10-70E2-B06E-E050-BB89AD430721","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Underlying cirrhosis","valueDescription":"Underlying cirrhosis","ValueMeaning":{"publicId":"6101874","version":"1","preferredName":"Underlying cirrhosis","longName":"6101874","preferredDefinition":"Underlying cirrhosis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66B0B956-020B-0F40-E053-F662850ADB27","latestVersionIndicator":"Yes","beginDate":"2018-03-05","endDate":null,"createdBy":"HLAINGY","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66B0B956-0224-0F40-E053-F662850ADB27","beginDate":"2018-03-05","endDate":null,"createdBy":"HLAINGY","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","deletedIndicator":"No"},{"value":"Familial Adenomatous Polyposis","valueDescription":"Familial Adenomatous Polyposis","ValueMeaning":{"publicId":"2716425","version":"1","preferredName":"Familial Adenomatous Polyposis","longName":"2716425","preferredDefinition":"Familial Adenomatous Polyposis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"41B659B0-4518-5521-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-12-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66B0B956-0238-0F40-E053-F662850ADB27","beginDate":"2018-03-05","endDate":null,"createdBy":"HLAINGY","dateCreated":"2018-03-05","modifiedBy":"ONEDATA","dateModified":"2018-03-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7F62E5-D63F-1CE6-E050-BB89AD4312A8","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"HLAINGY","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Type of genetic syndromes:","type":"Preferred Question Text","description":"Type of genetic syndromes:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Type of Genetic syndromes:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Underlying congenital abnormality:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B7F62E5-D6E7-1CE6-E050-BB89AD4312A8","latestVersionIndicator":"Yes","beginDate":"2015-07-22","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-22","modifiedBy":"HLAINGY","dateModified":"2018-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}